Cargando…

Case report: Incidental metastatic prostate cancer with undetectable PSA in pelvic lymphadenectomy

We report a patient that had a prior radical prostatectomy and negative PSA levels for two years and subsequently developed bladder cancer requiring radical cystectomy with mixed lymph nodes on final pathology. The nodes were found to be positive for both metastatic urothelial cell carcinoma and met...

Descripción completa

Detalles Bibliográficos
Autores principales: McLeay, Matthew T., Ellis, Lindsey, Weinstein, Stephen H., Murray, Katie S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991310/
https://www.ncbi.nlm.nih.gov/pubmed/29888198
http://dx.doi.org/10.1016/j.eucr.2018.05.009
_version_ 1783329786474528768
author McLeay, Matthew T.
Ellis, Lindsey
Weinstein, Stephen H.
Murray, Katie S.
author_facet McLeay, Matthew T.
Ellis, Lindsey
Weinstein, Stephen H.
Murray, Katie S.
author_sort McLeay, Matthew T.
collection PubMed
description We report a patient that had a prior radical prostatectomy and negative PSA levels for two years and subsequently developed bladder cancer requiring radical cystectomy with mixed lymph nodes on final pathology. The nodes were found to be positive for both metastatic urothelial cell carcinoma and metastatic prostatic adenocarcinoma based on immunohistochemical staining. Treatment for metastatic bladder cancer was pursued after radical cystectomy recovery.
format Online
Article
Text
id pubmed-5991310
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-59913102018-06-08 Case report: Incidental metastatic prostate cancer with undetectable PSA in pelvic lymphadenectomy McLeay, Matthew T. Ellis, Lindsey Weinstein, Stephen H. Murray, Katie S. Urol Case Rep Oncology We report a patient that had a prior radical prostatectomy and negative PSA levels for two years and subsequently developed bladder cancer requiring radical cystectomy with mixed lymph nodes on final pathology. The nodes were found to be positive for both metastatic urothelial cell carcinoma and metastatic prostatic adenocarcinoma based on immunohistochemical staining. Treatment for metastatic bladder cancer was pursued after radical cystectomy recovery. Elsevier 2018-05-14 /pmc/articles/PMC5991310/ /pubmed/29888198 http://dx.doi.org/10.1016/j.eucr.2018.05.009 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Oncology
McLeay, Matthew T.
Ellis, Lindsey
Weinstein, Stephen H.
Murray, Katie S.
Case report: Incidental metastatic prostate cancer with undetectable PSA in pelvic lymphadenectomy
title Case report: Incidental metastatic prostate cancer with undetectable PSA in pelvic lymphadenectomy
title_full Case report: Incidental metastatic prostate cancer with undetectable PSA in pelvic lymphadenectomy
title_fullStr Case report: Incidental metastatic prostate cancer with undetectable PSA in pelvic lymphadenectomy
title_full_unstemmed Case report: Incidental metastatic prostate cancer with undetectable PSA in pelvic lymphadenectomy
title_short Case report: Incidental metastatic prostate cancer with undetectable PSA in pelvic lymphadenectomy
title_sort case report: incidental metastatic prostate cancer with undetectable psa in pelvic lymphadenectomy
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991310/
https://www.ncbi.nlm.nih.gov/pubmed/29888198
http://dx.doi.org/10.1016/j.eucr.2018.05.009
work_keys_str_mv AT mcleaymatthewt casereportincidentalmetastaticprostatecancerwithundetectablepsainpelviclymphadenectomy
AT ellislindsey casereportincidentalmetastaticprostatecancerwithundetectablepsainpelviclymphadenectomy
AT weinsteinstephenh casereportincidentalmetastaticprostatecancerwithundetectablepsainpelviclymphadenectomy
AT murraykaties casereportincidentalmetastaticprostatecancerwithundetectablepsainpelviclymphadenectomy